Goeckeler W - Search Results

1

Stromal targeted therapy in bone metastatic prostate cancer: promise delivered.

Sartor O, Goeckeler W, Bruland O. Sartor O, et al. Among authors: goeckeler w. Asian J Androl. 2011 Nov;13(6):783-4. doi: 10.1038/aja.2011.120. Epub 2011 Aug 22. Asian J Androl. 2011. PMID: 21857688 Free PMC article. No abstract available.

2

Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.

Miyahira AK, Pienta KJ, Morris MJ, Bander NH, Baum RP, Fendler WP, Goeckeler W, Gorin MA, Hennekes H, Pomper MG, Sartor O, Tagawa ST, Williams S, Soule HR. Miyahira AK, et al. Among authors: goeckeler w. Prostate. 2018 Aug;78(11):775-789. doi: 10.1002/pros.23642. Epub 2018 May 1. Prostate. 2018. PMID: 29717499 Review.

3

Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.

Ma D, Hopf CE, Malewicz AD, Donovan GP, Senter PD, Goeckeler WF, Maddon PJ, Olson WC. Ma D, et al. Among authors: goeckeler wf. Clin Cancer Res. 2006 Apr 15;12(8):2591-6. doi: 10.1158/1078-0432.CCR-05-2107. Clin Cancer Res. 2006. PMID: 16638870

4

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Miller LS, Houchens D, Cheng R, Kaplan D, Goeckeler W. Schlom J, et al. Among authors: goeckeler w. Cancer Res. 1991 Jun 1;51(11):2889-96. Cancer Res. 1991. PMID: 1851665

5

The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.

Chakraborty M, Wansley EK, Carrasquillo JA, Yu S, Paik CH, Camphausen K, Becker MD, Goeckeler WF, Schlom J, Hodge JW. Chakraborty M, et al. Among authors: goeckeler wf. Clin Cancer Res. 2008 Jul 1;14(13):4241-9. doi: 10.1158/1078-0432.CCR-08-0335. Clin Cancer Res. 2008. PMID: 18594006 Free PMC article.

6

Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.

Schott ME, Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Cheng R, Kruper WJ Jr, Fordyce W, Goeckeler W. Schott ME, et al. Among authors: goeckeler w. Cancer. 1994 Feb 1;73(3 Suppl):993-8. doi: 10.1002/1097-0142(19940201)73:3+<993::aid-cncr2820731337>3.0.co;2-7. Cancer. 1994. PMID: 8306291

7

Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.

Goeckeler WF, Stoneburner LK, Kasi LP, Fossella FV, Price DR, Fordyce WA. Goeckeler WF, et al. Nucl Med Biol. 1993 Jul;20(5):657-61. doi: 10.1016/0969-8051(93)90036-t. Nucl Med Biol. 1993. PMID: 8358352

8

153Sm radiotherapeutic bone agents.

Goeckeler WF, Troutner DE, Volkert WA, Edwards B, Simon J, Wilson D. Goeckeler WF, et al. Int J Rad Appl Instrum B. 1986;13(4):479-82. doi: 10.1016/0883-2897(86)90028-0. Int J Rad Appl Instrum B. 1986. PMID: 3793505

9

Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.

Lattimer JC, Corwin LA Jr, Stapleton J, Volkert WA, Ehrhardt GJ, Ketring AR, Anderson SK, Simon J, Goeckeler WF. Lattimer JC, et al. Among authors: goeckeler wf. J Nucl Med. 1990 Aug;31(8):1316-25. J Nucl Med. 1990. PMID: 2384798 Free article.

10

Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.

Lattimer JC, Corwin LA Jr, Stapleton J, Volkert WA, Ehrhardt GJ, Ketring AR, Hewett JE, Simon J, Goeckeler WF. Lattimer JC, et al. Among authors: goeckeler wf. J Nucl Med. 1990 May;31(5):586-93. J Nucl Med. 1990. PMID: 2341893 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page